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Sinonasal polyposis (SNP) is a chronic inflammatory pathology of the nasal/paranasal cavities 
which affects from 1%-4% of the population. Although polyps seem to be a manifestation of 
chronic inflammation of nasal/paranasal sinus mucosa in both allergic and non-allergic subjects, the 
pathogenesis of nasal polyposis remains unknown. Interleukin-17A (IL-17A) is a key inflammatory 
cytokine in many disorders. Little attention has been paid to the role of IL-17A in chronic inflammatory 
disorders.
Objective: To investigate the expression of IL-17A in the SNP and verify if this expression is a 
marker of good or bad prognosis.
Method: Prospective study with 25 patients presenting with SNP were subjected to the 
immunohistochemistry technique. After a skin prick test, all patients were divided into atopic and 
nonatopic groups, and asthmatic or non-asthmatic.
Results: The IL-17A expression was observed in both atopic and nonatopic patients. The numbers 
of IL-17A positive cells were greater in nasal polyps of atopic patients than nonatopic (p = 0.0128).
Conclusion: These results indicate that IL-17A may play an important role in the pathology of 
SNP. Considering the inflammatory properties of IL-17A, this study suggests that it could increase 
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INTRODUCTION
Sinonasal polyposis (SNP) or chronic rhinosinusitis 
with nasal polyps is a chronic inflammatory pathology of 
the nasal and paranasal cavities1,2, which affects from 1% 
to 4% of the population and has a clear association with 
asthma, aspirin sensitivity and cystic fibrosis3. 
Patients with SNP typically present with nasal obs-
truction, rhinorrhea, hyposmia and reduced quality of 
life3,4. Although polyps seem to be a manifestation of the 
chronic inflammation of nasal/paranasal sinus mucosa in 
both allergic and non-allergic subjects, the pathogenesis 
of nasal polyposis remains unknown5,6, but it is probably 
a multifactorial disease with several different etiological 
factors, and chronic persistent inflammation is undoub-
tedly a major factor irrespective of the etiology5. Chronic 
inflammation of the mucous represents a challenge for 
the otolaryngologist.
The diagnosis of SNP is confirmed by nasal endos-
copy or a computed tomography (CT) scan1. Despite the 
major impact on quality of life7, in the literature there are 
no concerns about biomarkers involved in the pathoge-
nesis of nasal polyps and their possible contributions to 
the prognosis of SNP.
For more than two decades, immunologists have been 
using the so-called Th1/Th2 paradigm to explain most of the 
phenomena related to adaptive immunity. The Th17 cells, was 
recently described as a distinct lineage that does not share 
developmental pathways with either Th1 or Th2 cells. Shen 
et al. suggested that the imbalance of Treg/Th17 may play 
an important role in the development of SNP and that atopy 
may aggravate SNP8. Shen et al., on another study, suggested 
an important part of IL-17A in SNP, and demonstrated that 
expression of IL-17A was significantly upregulated in SNP 
patients and was more severe in atopic SNP9.
Little attention has been paid to the role of IL-17A 
in autoimmune and chronic inflammatory disorders, but 
evidence shows that the expression of IL-17A in chronic 
inflammatory skin diseases including psoriasis and atopic 
dermatitis10 is associated with a worst clinical course of 
the disease10,11.
Considering this lack of understanding of the me-
chanism which triggers inflammation and which hinders 
the development of new treatments for this disease, and 
the importance of the characterization of inflammatory 
mediators involved in the pathogenesis of SNP, the objec-
tive of this study was to investigate the IL-17A expression 




This was a longitudinal contemporary cohort in 
which twenty-five patients, who presented with sinonasal 
polyposis and who had been submitted to surgery for 
polyp resection, were evaluated. Patients without sinonasal 
polyposis identified in the computed tomography (CT) 
scan and nasal endoscopy were excluded from this study. 
All underwent clinical otorhinolaryngol evaluation with a 
nasal endoscopy, CT-scan, lung function test (spirometry) 
and the skin prick test before surgery. The preoperative CT 
scans were graded according to the Kennedy classification, 
to evaluate the extent of patients with SNP10. And all were 
investigated for allergy and positive history for asthma. 
They were divided in two groups: atopic (positive skin 
prick test) and non-atopic patients (negative skin prick 
test). The skin prick test was performed with 10 extracts: 
histamine (positive control), saline solution (negative 
control), D. pteronyssinus, D. farinae, Blomia tropicalis, 
Felix domesticus, Canis familiars, P. Americana, Asper-
gillus fumigatus and Alternaria alternate. The response 
was considered positive when there was a halo of 3 mm 
larger than that of the negative control.
The SNP patients were classified as having positive 
or negative history for asthma, which was confirmed by 
spirometry. This study was approved by the Research 
Ethics Committee, under protocol 0711/11 approved in 
06/02/11. All patients signed a term of informed consent 
for participation in the study.
Immunohistochemistry
After resection surgery, the polyps were subjected 
to the immunohistochemistry technique. Four-micrometer 
sections were cut from paraffin-embedded specimens. The 
Universal HRP-Polymer MACH 4 detection system (Biocare 
Medical, Concord, CA, USA) was used. In summary, after 
rinsing the sections in phosphate buffered saline with 





. Samples were initially incubated with specific 
or irrelevant antibodies for 1 hour at room temperature 
and subsequently with a solution containing a MACH 4 
Mouse Probe for 15 minutes. Diaminobenzidine plus a 
chromogen-substrate was used to develop antibody fixa-
tion. The specific monoclonal antibodies MEM-G/2 (Exbio, 
Praha, Czech Republic) recognize the free heavy-chain of 
anti-IL-17 (Santa Cruz Biotechnology, Santa Cruz, Califor-
nia, USA). An identical IgG1 isotype anti-desmin antibody 
which was run simultaneously with each sample served 
as a negative control.
Evaluation of stained sections
The immunohistochemical analysis was carried 
out on polyp tissue. Immunoreactivity was scored using 
a semi-quantitative scoring method by evaluating the per-
centage of positive cells. The cut-off scores for determining 
the positivity of IL-17A detected by immunohistochemistry 
were obtained by the receiver operating characteristic 
(ROC) curve analysis. ROC curve analysis was performed 
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for IL-17A expression. All sections were blindly analyzed 
using a light microscope with high-power fields (400x).
Statistical analysis
The ROC curve of staining performance for the 
determination of IL-17A cut-off expression was perfor-
med. The immunostaining scores were compared with the 
Mann-Whitney U test and the correlations of the immu-
nostaining scores were tested with Spearman correlation 
analysis. Comparative analyses between the groups were 
performed by the two-sided Fisher exact test. A p-value 
of less than 0.05 was considered significant. All statisti-
cal analyses were performed using the GraphPad Instat 
(version 5.0).
RESULTS
Clinical and Epidemiological Findings
The results included 25 patients with sinonasal 
polyposis submitted to nasal endoscopy and CT-scan to 
confirm the disease. The patient group consisted of 13 
(52%) males and 12 (48%) females aged between 35 and 
83 (mean: 48.8 years). The patients were divided into two 
groups: the group with a negative prick test (non-atopic 
group) consisted of 13 patients and the other group con-
sisted of 12 patients with positive prick test (atopic group). 
Of these patients, 17 presented asthma.
Using CT-scan evaluation, patients were classified 
according to the Kennedy et al. criteria to evaluate the 
extent of SNP (Graph 1). Most patients were classified as 
grade II.
The expression of IL-17A
The IL-17A expression was observed in epithelial 
and mainly by inflammatory infiltrating cells.
Graph 1. Kennedy classification of patients with SNP - Most patients 
were classified as grade II, namely, most patients had bilateral ethmoid 
disease, involving a paranasal sinus.
Graph 2. Expression of IL-17 and prick test result - The number of 
IL-17 positive cells were greater in nasal polyps of atopic patients 
than non-atopic.
On ROC curve analysis, the cut-off for positive 
results was 50% or greater (AUC = 0.892; p < 0.0001, 95% CI 
0.665 to 0.986) considering that, IL-17A could be detected 
in 12 out the 19 specimens evaluated (63.1%).
The number of IL-17A positive cells were greater in 
nasal polyps of atopic patients than non-atopic (p = 0.0128, 
RR = 0.33, 95% CI: 0.1497 to 0.7421). However, no stati-
cally significant result was found between asthmatic and 
non-asthmatic patients (p > 0.05) (Graph 2).
DISCUSSION
SNP is a chronic inflammatory condition associated 
with substantial impaired quality of life, reduced workplace 
productivity, and considerable medical treatment costs7,12. 
Despite the fact that this recent research evidence contribu-
tes to further comprehension of the pathophysiology of this 
chronic airway condition, the pathogenesis of SNP remains 
poorly understood and appears to be multifactorial, being 
associated with conditions such as atopy, asthma, cystic 
fibrosis, aspirin sensitivity and chronic rhinosinusitis13-15.
A diverse spectrum of alterations involving T-cell 
patterns, cytokine profiles, IgE production, microorganisms 
and immune system malfunctions should be associated 
with SNP pathogenesis16,17. In this context, this study eva-
luated the expression IL-17A in SNP.
This analysis showed that the IL-17A was expressed 
in 12 patients with SNP. Interestingly, the IL-17A expres-
sion tended to be significantly more frequent in patients 
with positive prick test, or in other words, atopic patients 
(p = 0.0128).
Agreeing with this study, experimental model 
showed that the absence of IL-17 in mice compromises 
the development of contact hypersensitivity reaction, 
reinforcing the importance of these cells in contact sen-
sitivity18. Studies suggest that IL-17A produced by cells 
are induction of proinflammatory cytokines (such as IL-1, 
IL-6 and TNF-α), chemokines (CXCL1, CXCL2, CXCL5 and 
CXCL8) and adhesion molecules (ICAM-1 and VCAM-1) 
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by epithelial and endothelial cells, thus leading to the 
recruitment of inflammatory cells and interaction of these 
cells with the epithelium19. This way, IL-17 increases the 
local inflammatory process20.
Based on the results of this study it can be specu-
lated that the expression of IL-17A in SNP may contribute 
to increase susceptibility to atopy in SNP, a factor that 
aggravates the disease.
CONCLUSION
The results of this study indicated that IL-17A may 
play an important role in the pathology of sinonasal poly-
posis. After considering the inflammatory properties of 
IL-17A, these authors suggest that IL-17A could increase 
susceptibility to atopy and SNP.
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